FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Traveres Filspari Converted to Full Approval

[ Price : $8.95]

FDA grants Travere Therapeutics full approval for Filspari (sparsentan) for slowing kidney function decline in adults with primary...

Info Collection on Drug Supply Security

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection revision entitled Pharmaceutical Distribution Supply Chai...

Guide on Device Patient Preference Information

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Incorporating Voluntary Patient Preference Information over...

Patient Preference Info in Product Life Cycle

[ Price : $8.95]

FDA publishes a draft guidance on incorporating voluntary patient preference information in medical device total life cycle regula...

Info Collection on Pediatric Device Development

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection reinstatement entitled Yale-Mayo Clinic Centers of Excellence ...

Abbott Recalls FreeStyle Libre 3 Sensors

[ Price : $8.95]

Abbott Diabetes Care recalls (Class 1) three lots of its FreeStyle Libre 3 sensors after finding that a small number of them may p...

Medtronic Laryngoscope Recall is Class 1

[ Price : $8.95]

FDA says a July Medtronic recall of some McGrath MAC Video Laryngoscopes due to potential battery problems is Class 1.

Glenmark Pays $25 Million in False Claims Case

[ Price : $8.95]

The Justice Department says Glenmark Pharmaceuticals, a generic drug manufacturer in Mahwah, NJ, will pay $25 million to resolve c...

Breas Medical Recalls Vivo 45 LS Ventilators

[ Price : $8.95]

Breas Medical recalls (Class 1) its Vivo 45 LS ventilators to update the use instructions after internal testing identified the po...

Lilly Reports Positive Data in Weekly Insulin Trials

[ Price : $8.95]

Eli Lilly says data from two Phase 3 clinical trials evaluating once-weekly insulin efsitora alfa in adults with Type 2 diabetes s...